NANOG and liver disorder: By contrast, control CD133-/CD49f- cells expression levels for KRT19, CD133, NANOG, SOX2, OCT4, and TLR4 were independent of IVIG (immune serum from people with HBV+ or HCV+ liver disease) or HBIG incubation.